VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TMOThermo Fisher Scientific Inc.
$464.61$172.7B
Research
OverviewAnalysisShould I Buy?
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTMOShould I Buy?

Buy or sell guide

TMO logo

Should I Buy TMO Stock Right Now?

A fast read on Wall Street conviction, live analyst commentary on X, and current valuation context for Thermo Fisher Scientific Inc..

Updated 2026-06-21

Wall Street currently rates TMO buy with a 12-month price target of $600 (+29.1% upside). The sections below cover the bull case, key risks, and latest earnings context for TMO.

Wall Street
Buy42 analysts
Consensus target
$600 target (+29.1%)Current price $464.61
Analyst sentiment
No recent analyst posts capturedWaiting for fresh posts
Earnings context
EPS beat 3.6%Reported Thu Apr 23

Is TMO a Buy Right Now?

According to 42 Wall Street analysts, TMO is currently rated Buy with a consensus 12-month price target of $600 — implying +29.1% upside from $464.61. Analyst targets range from $490 to $683.

Continue research

Full price target breakdownTMO stock analysisEarnings historyPrice historyOverview page

Wall Street verdict

Should I Buy TMO Stock? Here's What Analysts Think

42 analysts currently cover TMO. Below is their consensus rating, price target range, and implied upside.

According to 42 analysts, Thermo Fisher Scientific Inc. (TMO) is rated Buy with a consensus 12-month price target of $600 — representing 29% upside from today's price of $465. The bull case target is $683, the bear case is $490.

TMO logoTMO
Buy
From 42 analyst ratings
Current price
$464.61
Consensus Target
$600 (+29.1% upside)
Forward P/E
18.7x
Coverage
42 analyst ratings
High target$683
Low target$490

At $464.61, the consensus setup implies +29.1% versus the 12-month target.

  • 37 of 42 analysts lean Buy or Strong Buy, while 5 stay on Hold and 0 lean bearish.
  • TMO trades at roughly 18.7x forward earnings, so the bull case still depends on growth staying strong.
  • Analysts span a wide range from $490 to $683, so conviction matters as much as the consensus target.

Below, compare that institutional answer with the live analyst commentary on X for TMO right now.

Why the consensus reads Buy for TMO

88%
12%
37 Buy88%5 Hold12%0 Sell0%

Analyst ratings update weekly. Get TMO's next verdict in your inbox.

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

1 raised, 1 cut of 2 analystsPiper Sandler $510HSBC $540
Jun 2026

Live commentary on X

What Analysts Are Saying About Thermo Fisher Scientific Inc. Right Now

Real posts from high-reach stock analysts mentioning TMO, shown exactly as written. Sorted by engagement — most discussed first.

No recent posts captured

No high-reach analysts have posted about TMO in the last 7 days. Check back after the next earnings release or market-moving event.

View analyst price targetsSee earnings history

Should you buy TMO?

Is TMO a Buy, Hold, or Sell Right Now?

A structured look at the bull case, the risks, and the most recent earnings execution for TMO before you decide whether to buy, hold, or sell.

Current setup

TMO beat estimates last quarter. Below are the key reasons analysts remain constructive and the risks that could change that view.

Bull Case

What keeps the long thesis intact

  • 5G Market LeadershipT-Mobile holds approximately 35% of the wireless market share and its Ultra Capacity 5G network reaches nearly 98% of the U.S. population.
  • Strong Revenue GrowthQ1 2026 revenues reached $23.11 billion, marking an 11% year-over-year increase, with EPS at $2.27, exceeding forecasts.
  • Significant Capital ReturnsThe company expects to return up to $18.2 billion to stockholders in 2026 through share repurchases and dividends.
  • Broadband Expansion GoalsT-Mobile aims to reach 18-19 million total broadband customers by 2030 through its Fixed Wireless Access and fiber partnerships.
  • Successful Integration of U.S. CellularThe integration of U.S. Cellular is progressing well and is expected to complete by the end of 2026, enhancing market presence.
  • Positive Analyst SentimentAnalysts generally hold a positive view, with a consensus rating of 'Buy' and a median price target around $261.00.

Wall Street rates TMO buy, giving the bull case institutional backing from 42 analysts.

Watch Out For

What can break the setup quickly

  • Intense Industry CompetitionRivals like Verizon and AT&T are heavily investing in their networks, which could pressure T-Mobile's market share and pricing.
  • Concerns Over Subscriber GrowthThere are worries about slowing postpaid phone net adds and potential increases in churn rates, particularly in smaller markets.
  • High Debt LevelsT-Mobile carries a significant debt load of $86.95 billion as of December 2025, increasing financial risk in a rising interest rate environment.
  • Valuation ConcernsSome analysts note T-Mobile's higher P/E ratio compared to the industry average, raising concerns about valuation amidst rising operational costs.
  • Regulatory RisksThe telecommunications sector faces regulatory scrutiny, and macroeconomic factors could impact capital spending and consumer behavior.
  • Limited Broadband OfferingT-Mobile's current broadband offerings may be limited compared to competitors in the bundled fiber/mobility market.

Watch whether new negative commentary on TMO points to these structural risks or is simply reacting to short-term price moves.

TMO Earnings Reaction — What the Last Quarter Showed

Last Quarter

EPS
$5.44 vs $5.25 est.Beat 3.6%
Revenue
$11.0B vs $10.9B est.Beat 1.3%
Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into TMO consensus models and risk factors.

View Analysis

Should I Buy TMO?

Wall Street verdict, signals, and target summaries.

See Verdict

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TMO — Frequently Asked Questions

Quick answers to the most common questions about buying TMO stock.

Should I buy TMO stock right now?
Verdict

TMO looks attractive at current levels — Wall Street's consensus rating is "Buy" with a $600 price target (+29.1% upside from $464.61). This is informational only — verify the data and consider your own risk tolerance before deciding.

Is now a good time to buy TMO?
Timing

Timing depends on your horizon, but the data signals are: consensus rating "Buy" with +29.1% upside to the $600 target. Recent activity is mixed — 1 analysts raised and 1 cut targets in the past 30 days.

What is the price target for TMO stock?
Price Target

TMO's consensus 12-month price target is $600, set by 42 Wall Street analysts. The bull case high is $683 and the bear case low is $490. From the current price of $464.61, this implies +29.1% upside.

Is TMO overvalued or undervalued?
Valuation

TMO appears undervalued — the $600 consensus target is +29.1% above today's $464.61. It trades at a forward P/E of 18.7x. Targets range from $490 (bear) to $683 (bull), reflecting different assumptions about growth and margins.

Should I buy TMO before earnings?
Earnings

TMO reports next quarter. Earnings-week moves are volatile — historically, analyst targets revise upward after a beat and downward after a miss. The current consensus is "Buy" with a $600 target. Consider position sizing rather than going all-in pre-print.

What are analysts saying about TMO stock?
Coverage

Of 42 analysts covering Thermo Fisher Scientific Inc. (TMO): 0 Strong Buy, 37 Buy, 5 Hold, 0 Sell, 0 Strong Sell — a "Buy" consensus. The 12-month price target is $600 (range $490–$683). Bullish analysts outnumber bearish by more than 2-to-1.

What are the risks of buying TMO stock?
Risks

No analyst currently rates TMO a Sell, but the 5 Hold ratings reflect concerns about valuation, execution risk, or near-term catalysts. See the Bull vs. Risk cards above for the specific theses on Thermo Fisher Scientific Inc..

This page is for informational purposes only and does not constitute financial advice. Always conduct your own research before investing.